Furthermore, many MDS patients have been shown to acquire mutations in genes with a role in epigenesis, including TET2, IDH1, IDH2, ASXL1, EZH2 and DNMT3A (as reviewed in [173]). This evidence concerns the gene EZH2 and myelodysplastic syndrome.